Algernon Pharmaceuticals (TSE:AGN) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Algernon Pharmaceuticals, a Canadian pharmaceutical development company, has announced an increase in their private placement from $150,000 to $235,200, offering units at $0.12 each, which includes a common share and a purchase warrant. The purchase warrants grant the holder the right to buy additional shares at $0.24 within two years, with the possibility of an accelerated expiry. Proceeds from the placement, expected to close on August 16, 2024, will fund the company’s working capital.
For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money